Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
December 19 2022 - 6:00AM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, today announced the full commercial
release of AcQMap 8.5. This next generation software platform
introduces new algorithms and features to further improve the
accuracy and workflow of non-contact ultrasound-based anatomical
reconstruction.
“AcQMap 8.5 represents an important step forward in our
technology roadmap with a specific focus on improving procedure
workflow and physician experience,” said Derrick Chou, Senior Vice
President & Chief Technology Officer of Acutus Medical. “This
release enables physicians to further leverage AcQMap’s
differentiated non-contact ultrasound capabilities for higher
anatomical accuracy while providing a workflow that fits with
existing clinical practice. The full market release of AcQMap 8.5
is an important driver of our growth plans in 2023 and
thereafter.”
The AcQMap 8.5 software release enhances Acutus’ unique
ultrasound capabilities by providing more fidelity and definition
around key atrial structures like the pulmonary veins and left and
right atrial appendage as well as highlighting open structures on
the surface (e.g., mitral valve), making them easy to confidently
locate, visualize, and incorporate into an individualized treatment
strategy. Additionally, new workflow tools, like on-the-fly
editing, have been added to further increase the efficiency and
accuracy of the ultrasound-based anatomical reconstruction process.
The updated algorithms in AcQMap 8.5 also improve catheter
localization and visualization with a more accurate anatomical
reference. Ultimately, AcQMap 8.5 provides a higher fidelity of
anatomical accuracy and workflow efficiencies which allow for
broader utilization of the AcQMap technology.
Acutus’ single beat, whole chamber, non-contact
electro-anatomical mapping uniquely provides a holistic view of
each patient’s disease enabling guidance of an individualized and
optimized treatment approach. “AcQMap’s non-contact, ultrasound
technology enables me to create a high-fidelity anatomy faster than
most other conventional systems. This new software has been
instrumental in getting better definition and catheter
localization, particularly around structures which are difficult to
achieve with conventional mapping technology. This accurate
anatomy, combined with unique and powerful diagnostic and
visualization algorithms, enables me to take a personalized
approach when treating my patients with difficult-to-manage
arrhythmias,” said Douglas Gibson, MD, Director of Cardiac
Electrophysiology at Scripps Clinic
To learn more about Acutus Medical’s complete portfolio of
diagnostic, access and therapy products, please visit
https://acutusmedical.com.
About Acutus MedicalAcutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
Follow Acutus Medical on: Twitter, LinkedIn,
YouTube and Facebook.
Investor ContactCaroline Corner
415-202-5678caroline.corner@westwicke.com
Media Contact Peter
Neems442-232-6094peter.neems@acutus.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Apr 2024 to May 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From May 2023 to May 2024